Sartorius Stedim Biotech annual net debt
2020
2021
2022
2023
2024
2025
Sartorius Stedim Biotech Net Debt Growth & History (DIM)
Sartorius Stedim Biotech's net debt was €2.17B for fiscal 2025.
View full Sartorius Stedim Biotech company overviewSartorius Stedim Biotech annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2.17B | −€17.5M | −0.80% |
| 2024 | 2024-12-31 | €2.19B | −€1.37B | −38.56% |
| 2023 | 2023-12-31 | €3.57B | €2.54B | +246.62% |
| 2022 | 2022-12-31 | €1.03B | €626.7M | +155.93% |
| 2021 | 2021-12-31 | €401.9M | −€125.4M | −23.78% |
| 2020 | 2020-12-31 | €527.3M | — | — |
Sartorius Stedim Biotech quarterly net debt
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €2.20B | −€71.3M | −3.14% |
| Q1 2026 | 2026-03-31 | €2.09B | −€131.8M | −5.92% |
| Q4 2025 | 2025-12-31 | €2.17B | — | — |
| Q2 2025 | 2025-06-30 | €2.27B | — | — |
| Q1 2025 | 2025-03-31 | €2.23B | — | — |
Sartorius Stedim Biotech net debt trends
Over the last five fiscal years, Sartorius Stedim Biotech's net debt increased from €527.3M to €2.17B, a change of €1.65B. The latest reported quarter, Q2 2026, shows €2.20B.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sartorius Stedim Biotech source filings ↗